Back to Search
HANA NAJAR, M.D.
M.D.
Gynecology Physician
NPI: 1235271008Individual
Specialties, Licenses & Credentials
Gynecology PhysicianPrimary
Obstetrics & Gynecology — Gynecology
Code: 207VG0400X
HN037039(MI)
Research & Publications (8)
Topical CpG enhances the response of murine malignant melanoma to dacarbazine.
PMID 18368132·J Invest Dermatol·2008
7-preclinical
Topical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do.
PMID 17634951·Eur J Immunol·2007
7-preclinical
Topical resiquimod promotes priming of CTL to parenteral antigens.
PMID 19660592·Vaccine·2009
7-preclinical
Chronic granulomatous disease with unusual clinical manifestation, outcome, and pattern of inheritance in an Iranian family.
PMID 16783468·J Clin Immunol·2006
5-case
Dendritic cells, pulsed with lysate of allogeneic tumor cells, are capable of stimulating MHC-restricted antigen-specific antitumor T cells.
PMID 16720928·Med Oncol·2006
8-other
Susceptibility of Streptococcus pneumoniae to penicillin in the state of Minas Gerais, Brazil from 1997-2004.
PMID 16410890·Braz J Infect Dis·2005
4-observational
Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
PMID 15528345·J Immunol·2004
7-preclinical
Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL.
PMID 15102096·J Invest Dermatol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2142 MONROE ST
DEARBORN, MI 48124 - Phone
- (313) 730-8000
Quick Facts
- NPI
- 1235271008
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile